Results 191 to 200 of about 10,219 (294)
Local field potentials survey to guide DBS programming in Parkinson's disease: a clinical-neurophysiological longitudinal study. [PDF]
D'Onofrio V +9 more
europepmc +1 more source
ABSTRACT Objective Accurate localization of epileptogenic tubers (ETs) in patients with tuberous sclerosis complex (TSC) is essential but challenging, as these tubers lack distinct pathological or genetic markers to differentiate them from other cortical tubers.
Tinghong Liu +11 more
wiley +1 more source
Impact of the COVID-19 Pandemic on Cochlear Implant Usage in Children. [PDF]
Kfoury P +7 more
europepmc +1 more source
Transform Learning: Procedural Reasoning Without Programs in Semantic Topology Architectures
Marcelo Emanuel Paradela Teixeira
openalex +1 more source
Life‐Threatening Bradycardia in Anti‐NMDA‐Receptor Encephalitis and a Novel Use for Permanent Pacing
ABSTRACT Background Pediatric anti‐NMDA receptor encephalitis (pNMDARE) is an autoantibody‐mediated disorder that can cause severe autonomic dysfunction, including symptomatic bradycardia and asystole. Dysautonomia can last for years, making it very challenging to manage.
Sarah Tucker +9 more
wiley +1 more source
Pulsed Field Ablation in Patients With Cardiac Implantable Electric Devices: Vigilance Is Warranted. [PDF]
Koop BE, Albrecht EM, Lecy E, Kippola J.
europepmc +1 more source
ABSTRACT Objective People with epilepsy (PWE) may experience cognitive deficits but fail to undergo formal evaluation. This study compares cognitive status between PWE and healthy controls in the West African Republic of Guinea. Methods A cross‐sectional, case–control study was conducted in sequential recruitment phases (July 2024–July 2025) at Ignace ...
Maya L. Mastick +14 more
wiley +1 more source
From Evidence to Insight: An Umbrella Review of Computational Thinking Research Syntheses. [PDF]
Zhang J, Wu Y, Ning Y, Shi Y.
europepmc +1 more source
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source

